Gathering Novel Circulating Exosomal microRNA in Osteosarcoma Cell Lines and Possible Implications for the Disease

Nicola Cuscino, Lavinia Raimondi, Angela De Luca, Claudia Carcione, Giovanna Russelli, Laura Conti, Jacopo Baldi, Pier Giulio Conaldi, Gianluca Giavaresi, Alessia Gallo

Research output: Contribution to journalArticle

Abstract

One of the goals of personalized medicine is to understand and treat diseases with greater precision through the molecular profile of the patient. This profiling is becoming a powerful tool for the discovery of novel biomarkers that can guide physicians in assessing, in advance, the disease stage, and monitoring disease progression. Circulating miRNAs and exosomal miRNAs, a group of small non-coding RNAs, are considered the gold standard diagnostic biomarkers for human diseases. We have previously demonstrated that osteosarcoma-derived exosomes are able to influence crucial mechanisms inside tumor niches, inducing osteoclast differentiation, and sustaining bone resorption activity. Here we discovered, through Next-Generation Sequencing (NGS), eight novel microRNAs in three different osteosarcoma cell lines, and assessed the selective packaging into the exosomes released. We then investigated, as proof-of-principle, the presence of the novel microRNAs in osteosarcoma patient samples, and found that 5 of the 8 novel microRNAs were more present in circulating exosomes of osteosarcoma patients compared with the controls. These results raise a question: Could the 8 novel microRNAs play a role for osteosarcoma pathogenesis? Although still premature, the results are encouraging, and further studies with a validation in a larger cohort are needed.

Original languageEnglish
Pages (from-to)1-11
Number of pages11
JournalCancers
Volume11
Issue number12
DOIs
Publication statusPublished - Dec 3 2019

Keywords

  • exosomes
  • liquid biopsy
  • microRNAs

Cite this

Gathering Novel Circulating Exosomal microRNA in Osteosarcoma Cell Lines and Possible Implications for the Disease. / Cuscino, Nicola; Raimondi, Lavinia; De Luca, Angela; Carcione, Claudia; Russelli, Giovanna; Conti, Laura; Baldi, Jacopo; Conaldi, Pier Giulio; Giavaresi, Gianluca; Gallo, Alessia.

In: Cancers, Vol. 11, No. 12, 03.12.2019, p. 1-11.

Research output: Contribution to journalArticle

@article{643d5be3441c499b819e1837c3fcc228,
title = "Gathering Novel Circulating Exosomal microRNA in Osteosarcoma Cell Lines and Possible Implications for the Disease",
abstract = "One of the goals of personalized medicine is to understand and treat diseases with greater precision through the molecular profile of the patient. This profiling is becoming a powerful tool for the discovery of novel biomarkers that can guide physicians in assessing, in advance, the disease stage, and monitoring disease progression. Circulating miRNAs and exosomal miRNAs, a group of small non-coding RNAs, are considered the gold standard diagnostic biomarkers for human diseases. We have previously demonstrated that osteosarcoma-derived exosomes are able to influence crucial mechanisms inside tumor niches, inducing osteoclast differentiation, and sustaining bone resorption activity. Here we discovered, through Next-Generation Sequencing (NGS), eight novel microRNAs in three different osteosarcoma cell lines, and assessed the selective packaging into the exosomes released. We then investigated, as proof-of-principle, the presence of the novel microRNAs in osteosarcoma patient samples, and found that 5 of the 8 novel microRNAs were more present in circulating exosomes of osteosarcoma patients compared with the controls. These results raise a question: Could the 8 novel microRNAs play a role for osteosarcoma pathogenesis? Although still premature, the results are encouraging, and further studies with a validation in a larger cohort are needed.",
keywords = "exosomes, liquid biopsy, microRNAs",
author = "Nicola Cuscino and Lavinia Raimondi and {De Luca}, Angela and Claudia Carcione and Giovanna Russelli and Laura Conti and Jacopo Baldi and Conaldi, {Pier Giulio} and Gianluca Giavaresi and Alessia Gallo",
year = "2019",
month = "12",
day = "3",
doi = "10.3390/cancers11121924",
language = "English",
volume = "11",
pages = "1--11",
journal = "Cancers",
issn = "2072-6694",
publisher = "MDPI AG",
number = "12",

}

TY - JOUR

T1 - Gathering Novel Circulating Exosomal microRNA in Osteosarcoma Cell Lines and Possible Implications for the Disease

AU - Cuscino, Nicola

AU - Raimondi, Lavinia

AU - De Luca, Angela

AU - Carcione, Claudia

AU - Russelli, Giovanna

AU - Conti, Laura

AU - Baldi, Jacopo

AU - Conaldi, Pier Giulio

AU - Giavaresi, Gianluca

AU - Gallo, Alessia

PY - 2019/12/3

Y1 - 2019/12/3

N2 - One of the goals of personalized medicine is to understand and treat diseases with greater precision through the molecular profile of the patient. This profiling is becoming a powerful tool for the discovery of novel biomarkers that can guide physicians in assessing, in advance, the disease stage, and monitoring disease progression. Circulating miRNAs and exosomal miRNAs, a group of small non-coding RNAs, are considered the gold standard diagnostic biomarkers for human diseases. We have previously demonstrated that osteosarcoma-derived exosomes are able to influence crucial mechanisms inside tumor niches, inducing osteoclast differentiation, and sustaining bone resorption activity. Here we discovered, through Next-Generation Sequencing (NGS), eight novel microRNAs in three different osteosarcoma cell lines, and assessed the selective packaging into the exosomes released. We then investigated, as proof-of-principle, the presence of the novel microRNAs in osteosarcoma patient samples, and found that 5 of the 8 novel microRNAs were more present in circulating exosomes of osteosarcoma patients compared with the controls. These results raise a question: Could the 8 novel microRNAs play a role for osteosarcoma pathogenesis? Although still premature, the results are encouraging, and further studies with a validation in a larger cohort are needed.

AB - One of the goals of personalized medicine is to understand and treat diseases with greater precision through the molecular profile of the patient. This profiling is becoming a powerful tool for the discovery of novel biomarkers that can guide physicians in assessing, in advance, the disease stage, and monitoring disease progression. Circulating miRNAs and exosomal miRNAs, a group of small non-coding RNAs, are considered the gold standard diagnostic biomarkers for human diseases. We have previously demonstrated that osteosarcoma-derived exosomes are able to influence crucial mechanisms inside tumor niches, inducing osteoclast differentiation, and sustaining bone resorption activity. Here we discovered, through Next-Generation Sequencing (NGS), eight novel microRNAs in three different osteosarcoma cell lines, and assessed the selective packaging into the exosomes released. We then investigated, as proof-of-principle, the presence of the novel microRNAs in osteosarcoma patient samples, and found that 5 of the 8 novel microRNAs were more present in circulating exosomes of osteosarcoma patients compared with the controls. These results raise a question: Could the 8 novel microRNAs play a role for osteosarcoma pathogenesis? Although still premature, the results are encouraging, and further studies with a validation in a larger cohort are needed.

KW - exosomes

KW - liquid biopsy

KW - microRNAs

U2 - 10.3390/cancers11121924

DO - 10.3390/cancers11121924

M3 - Article

C2 - 31816885

VL - 11

SP - 1

EP - 11

JO - Cancers

JF - Cancers

SN - 2072-6694

IS - 12

ER -